Hormone therapy for prostate cancer has come a long way in the past ... "Right now, there's a level of art to figuring out which agents to use," says Durado Brooks, MD, MPH, director of prostate ...

This therapy employs systemic administration of the tissue hormone interferon ... well to these agents," says Sibilia, who is also Deputy Head of the Comprehensive Cancer Center of MedUni Vienna ...

Also relevant to discussion of the possible long-term impact of hormonal agent administration around the time of surgery is the suggestion that breast cancer surgery in premenopausal women might have ...

Seth Wander, MD, PhD, discusses the tolerability of selective estrogen receptor degraders and next-generation anti-estrogen ...

This includes radiation; although thought to be synergistic with a variety of agents, it can be immunosuppressive reducing PD-L1 expression. Patients who are clinical trial candidates are often those ...